-
Official: Newly crowned virus infected persons have been cured and discharged from the hospital within 6 months of refusing to donate blood
Time of Update: 2021-01-09
Guidelines stipulate that in order to ensure the safety of blood for clinical use, such as blood donation after the emergence of new coronavirus infection-related symptoms, blood donors should promptly return to the blood station; (Complete)
-
1.1 billion antidepressants have been reviewed in China and the West
Time of Update: 2021-01-07
hydrochloric acid Lositin intestinal capsule evaluation enterprises gathered 3, respectively, Pelte Pharmaceuticals, Stone Pharmaceuticals Europe, Chinese and Western Pharmaceuticals.
-
Giniteni is listed as a clinically in urgent need of new drugs from abroad
Time of Update: 2021-01-07
Reporters learned on the 24th, for the treatment of adult patients with FLT3 mutation relapsed or refractory acute myeloid leukemia fumaric acid ginni tablets (collectively referred to as gilitinib) was included in the Third Batch of China's State Drug Administration Drug Review Center (CDE) clinically in urgent need of foreign new drugs list.
-
The first major national science and technology infrastructure for translational medicine was completed
Time of Update: 2021-01-02
as one of the 16 major scientific and technological infrastructures prioritized during china's 12th Five-Year Plan period, this launch ceremony marks the official step of transforming medical facilities from the stage of comprehensive construction to the stage of leading the medical industry and developing at full speed.
-
The European Union has approved a new crown vaccine for conditional listing
Time of Update: 2021-01-02
Pharma.com December 22 - The European Medicines Agency on the 21st of the United States Pfizer Pharmaceutical Co., Ltd. and The German bio-new technology company jointly developed a new crown vaccine safety and effectiveness of a positive assessment, the European Commission subsequently approved the vaccine in the European Union conditional listing.
-
Two supplementary applications for iodized kesha alcohol injections from Yangzijiang Pharmaceutical Group were approved
Time of Update: 2021-01-02
Medicine Network December 21st, December 18th, the official website of the State Drug Administration shows that Yangzijiang Pharmaceutical Group's iodized kesha alcohol injection two supplementary app
-
Clinical trials of new coronary pneumonia drugs have been conducted in many African countries
Time of Update: 2021-01-02
, director of the African Center for Disease Control and Prevention, said Africa needs to conduct large-scale clinical trials of new crown pneumonia drugs to respond more effectively to outbreaks in Africa.
-
Guorui Pharmaceuticals liquorite bhutto morphine injection imitation 3 types of listing applications were accepted
Time of Update: 2021-01-02
Pharmaceutical network December 21st, before the CDE official website shows that the national pharmaceutical group Guorui Pharmaceuticals' liquorite acid Bhutto morphine injection imitation 3 types of
-
Expert: The new coronavirus inactivated vaccine will be better immunized twice
Time of Update: 2021-01-02
on the immune mechanism that works after vaccination, Wang Huaqing said that after vaccination, the body's immune system mainly has T lymphocytes and B lymphocytes in play.
-
New BTK inhibitors bring light to the treatment of blood tumors
Time of Update: 2021-01-01
Medicine Network December 28 - Recently, reporters from the 62nd annual meeting of the American Society of Hematology (ASH) learned that Bruton tyrosine kinase (BTK) inhibitor Aubutinib for recurrence / refragrant sleeve lymphoma (MCL) and recurring / refractic chronic lymphoblastic leukemia (CLL ) / small cell leukemia (SLL) in two clinical studies have shown good overall remission rate and safety.
-
Led by Professor Wu Yilong: 75.5 months! One of the longest lifetimes of targeted assisted therapy for lung cancer
Time of Update: 2021-01-01
For early non-small cell lung cancer (NSCLC), there is still a risk of recurrence after postoperative assisted chemotherapy. according to the International Lung Cancer Research Association (IASLC), t
-
The country's five new crown vaccines entered Phase III. Clinically, four of which were developed in Beijing
Time of Update: 2021-01-01
during the epidemic, Beijing established a war-time mechanism, issued "10" to strengthen the new crown pneumonia science and technology, organized the dominant forces to carry out vaccines, diagnostic reagents, drug research and development, strengthen big data, artificial intelligence and new materials and other technical applications, science and technology to fight the epidemic made important progress.
-
Spread faster? Ying said the discovery of a mutated new coronavirus has been notified to the World Health Agency
Time of Update: 2020-12-24
Medicine Network December 15, according to the "Central News Agency" reported that local time on the 14th, British Health Secretary Hancock said that in England found faster than the new coronavirus transmission of new strains of the virus, has been informed of the World Health Organization (WHO).
-
Lianhua Qing plague was approved by the Zimbabwe Register
Time of Update: 2020-12-23
Since the outbreak of new coronary pneumonia, Lianhua Qing plague capsules (particles) have been jointly issued by the National Health And Wellness Commission and the State Administration of Traditional Chinese Medicine, "new coronavirus pneumonia diagnosis and treatment program" (trial 4/5/6/7/8 edition) and more than 20 provinces and cities of the new coronary pneumonia diagnosis and treatment program recommended.
-
Ted Pharmaceuticals generic 4 classes of benzene shun aquco ammonium injection into the administrative approval stage
Time of Update: 2020-12-23
Table: Benzene Shun Aquku ammonium injection consistency evaluation in review Source: MED2.0 China Drug Review Database Minet data show that currently only Hengrui Pharma submitted a supplementary application for the consistent evaluation of benzene Shun Aquku ammonium injection consistency evaluation, Qilu, Yangzijiang, Beijing Ted Pharmaceuticals and other enterprises to the new classification of production, of which Beijing Ted Pharmaceutical products have entered the administrative approval stage; source: Mi Net database, state drug regulatory agency official website
-
Qilu Pharmaceutical Malay acid Isola tablets through a consistent evaluation of supplementary applications
Time of Update: 2020-12-23
Malay acid Isola tablet manufacturer Source: Minet MID drug index comprehensive database Minet data show that in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal Isola Ding sales of 14.59 million yuan, Japan New Pharmaceutical Co., Ltd. accounted for 83.37 percent of the market share.
-
New international research: Two blood molecules may predict the development of Alzheimer's disease
Time of Update: 2020-12-13
MEDICINE NETWORK, Dec. 2 (Xinhua) -- Levels of two molecules in the blood may predict future cognitive decline and the development of Alzheimer's disease in patients with mild cognitive impairment, according to a new study of neurodegenerative diseases published in nature-aging, a professional academic journal of Springer Nature.
-
Sun Chunlan: Scientific rigour to do a good job of new crown vaccine research and development and production preparations
Time of Update: 2020-12-13
Medicine Network December 3 , Chinese Vice Premier Sun Chunlan , State Councilor Wang Yong in Beijing on December 2 to investigate the development and production of new coronavirus vaccine preparation
-
The National Cancer Center will promote a multidisciplinary model of cancer diagnosis and treatment
Time of Update: 2020-11-06
Cai Jianqiang, deputy director of the National Cancer Center and vice president of the Oncology Hospital of the Chinese Academy of Medical Sciences, said at the 3rd China Cancer Summit Forum that under the multidisciplinary diagnosis and treatment model (MDT), the development of accurate personalized treatment plan can maximize the lives of patients with advanced cancer, and even give them a chance of cure.
-
Stem cell treatment of diabetes clinical transformation research by the national key projects
Time of Update: 2020-11-06
Medicine Network October 27th by Shanghai Jiaoda University School of Medicine affiliated Ruijin Hospital, Chinese Min People's Liberation Army Air Force Military Medical University affiliated Xijing Hospital, Beijing Jiyuan Biotech Co., Ltd. jointly declared the 2020 national key research and development plan "stem cell and transformation research" key special projects, human GLP-1 and FGF21 double-factor high-expression self-expressing fat-filled stem cell input treatment type 2 diabetes clinical research, in October was approved by the Ministry of Science and Technology.
